We use cookies for a better user experience. Read our Privacy Policy
I Agree
Veterinary Molecular Diagnostics Market Trends, 2020-2030
Research and development activities are likely to play a key role in driving the global veterinary molecular diagnostics market in the upcoming decade. Some of the recent novel and groundbreaking discoveries in diverse diagnostics and therapeutic tools pertaining to animal health are expected to open up new avenues for the players involved in the current veterinary molecular diagnostics market. Considerable progress made in the detection, management, and treatment of infectious and non-infectious diseases among animals is expected to fuel the demand for veterinary molecular diagnostics during the forecast period.
Innovations in the field of veterinary molecular diagnostics are primarily driven by advancements in technology, research, and increasing investments from private as well as non-private business entities. Progress in veterinary molecular diagnostics has also provided a considerable boost to the economies and food security of several developing nations, including India and China– a factor that is expected to boost the global veterinary molecular diagnostics market during the assessment period. The past and newly developed veterinary molecular diagnostic techniques play an imperative role in the detection and identification of new and emerging pathogens in livestock due to which, the adoption rates continue to move in the upward trajectory.
At the back of these factors, the global veterinary molecular diagnostics market is on course to attain a market value of US$ 1.1 Bn by the end of 2030.
Request a sample to get extensive insights into the Veterinary Molecular Diagnostics Market
The advent of new vaccines and recent progress made by veterinary molecular diagnostic techniques by opting for a genomic approach are anticipated to improve the overall state of veterinary molecular diagnostics worldwide and management of a range of infectious veterinary diseases. Noteworthy progress made by DNA sequencing platforms and major developments in the data analysis space are also some of the key factors that are expected to provide a solid boost to the overall development of the global veterinary molecular diagnostics market during the assessment period. A number of private as well as government laboratories involved in the current market landscape are increasingly focusing on improving the accuracy of their veterinary molecular diagnostics to gain a considerable advantage.
The increasing adoption of DNA sequencing platforms and the high-throughput data generated by leveraging these platforms are increasingly being analyzed by using computational genomics and bioinformatics– a trend that is projected to gain momentum over the course of the forecast period. Improvements in the data analysis space is expected to present a number of opportunities to the players involved in the current veterinary molecular diagnostics market to develop improved therapeutic and veterinary molecular diagnostics tools. This factor is expected to shape the growth of the global veterinary molecular diagnostics market.
To understand how our report can bring difference to your business strategy, Ask for a brochure
For several decades, conventional laboratory diagnostics for veterinary pathogens have primarily relied on various techniques, including neutralization, enzyme-linked Immunosorbent Assay (ELISA), compliment fixation, and agar gel immunodiffusion. However, due to advancements in technology, veterinarians around the world are increasingly using new veterinary molecular diagnostic techniques, including Western blot and polymerase chain reaction (PCR), which is estimated to increase the demand for veterinary molecular diagnostics in the upcoming years. Although the adoption of conventional techniques remains steady, the incorporation of new molecular techniques is on the rise. Improved immunoassays, increased use of biosensors, adoption of nucleic acid diagnostics, and adoption of preteomic technologies are expected to pave the way for a bright future for the veterinary molecular diagnostics market.
The onset of the novel COVID-19 pandemic is expected to have a strong impact on the overall growth of the global veterinary molecular diagnostics market in 2020. As the majority of the healthcare fraternity and research activities is increasingly focusing on the discovery of a new vaccine for the novel COVID-19 disease, the growth of the veterinary molecular diagnostics market is expected to remain slower than initial projections. The ongoing pandemic is likely to cut-short investments for the development of new veterinary molecular diagnostic techniques, particularly in 2020, as the primary focus continues to remain on pathological tests related to human beings.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Veterinary Molecular Diagnostics Market
Analysts’ Viewpoint
The global veterinary molecular diagnostics market is expected to expand at an impressive CAGR of ~8% during the forecast period. Increase in the number of research and development activities, entry of new veterinary molecular diagnostic methods, advancements in technology, rise in prevalence of vector-borne diseases, and growth in pet ownership worldwide are anticipated to drive the veterinary molecular diagnostics market during the forecast period. Players involved in the current market should focus on research and development, and explore the potential of collaborating with other players in the market to strengthen their market position.
Veterinary Molecular Diagnostics Market – Segmentation
TMR’s study on the global veterinary molecular diagnostics market includes information divided into the following segments: product type, technology, disease type, animal type, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global veterinary molecular diagnostics market are discussed in detail.
|
Product Type |
|
|
Technology |
|
|
Disease Type |
|
|
Animal Type |
|
|
End User |
|
|
Region |
|
The global veterinary molecular diagnostics market was worth US$ 479.3 Mn and is projected to reach a value of US$ 1.1 Bn by the end of 2030
Veterinary molecular diagnostics market is anticipated to grow at a CAGR of 8% during the forecast period
North America accounted for a major share of the global veterinary molecular diagnostics market
Veterinary Molecular Diagnostics Market is driven by rise in obesity among pets and increase in awareness about veterinary diagnostics
Key players in the global veterinary molecular diagnostics market include IDEXX Laboratories, Inc., Thermo Fisher Scientific, Inc., Zoetis, Inc., Neogen Corporation, bioMérieux SA, QIAGEN N.V., Biomedica Medizinprodukte GmbH & Co KG, Bioneer, VCA, Inc. (subsidiary of Mars, Incorporated), and ID.VET.
1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights
2. Assumptions and Research Methodology
2.1. Assumptions and Acronyms Used
2.2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Key Industry Developments
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunity
4.4. Global Veterinary Molecular Diagnostics Market Forecast
4.5. Global Veterinary Molecular Diagnostics Market Outlook
5. Market Outlook
5.1. Key Industrial Events (Licensing Partnership/Merger & Acquisition)
5.2. Pet Ownership Statistics
5.3. List of Pathogens for responsible for Canine, Feline, and Equine Diseases
5.4. Covid-19 Impact Analysis
5.5. Pros and Cons of Each Type of PCR Test
5.6. Technological Advancement
5.7. Most commonly Used Instruments for Veterinary Diagnostics
5.8. Veterinary Medical Device Regulation
6. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type
6.1. Introduction
6.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
6.3. Global Veterinary Molecular Diagnostics Market Forecast, by Product Type
6.3.1. Instruments & Software
6.3.2. Kits & Reagents
6.3.3. Services
6.4. Global Veterinary Molecular Diagnostics Market Analysis, by Product Type
7. Global Veterinary Molecular Diagnostics Market Analysis, by Technology
7.1. Introduction
7.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
7.3. Global Veterinary Molecular Diagnostics Market Forecast, by Technology
7.3.1. Conventional PCR
7.3.2. Singleplex PCR
7.3.3. Multiplex PCR
7.3.4. Real-time PCR
7.3.5. Others
7.4. Global Veterinary Molecular Diagnostics Market Analysis, by Technology
8. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type
8.1. Introduction
8.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
8.3. Global Veterinary Molecular Diagnostics Market Forecast, by Disease Type
8.3.1. Vector-borne Diseases
8.3.2. Respiratory Pathogens
8.3.3. Diarrhea Pathogens
8.3.4. Others
8.4. Global Veterinary Molecular Diagnostics Market Analysis, by Disease Type
9. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type
9.1. Introduction
9.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
9.3. Global Veterinary Molecular Diagnostics Market Forecast, by Animal Type
9.3.1. Companion Animals
9.3.1.1. Canine
9.3.1.2. Feline
9.3.1.3. Others
9.3.2. Livestock Animals
9.4. Global Veterinary Molecular Diagnostics Market Analysis, by Animal Type
10. Global Veterinary Molecular Diagnostics Market Analysis, by End-user
10.1. Introduction
10.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
10.3. Global Veterinary Molecular Diagnostics Market Forecast, by End-user
10.3.1. Hospitals/Clinics
10.3.2. Reference Laboratories
10.4. Global Veterinary Molecular Diagnostics Market Analysis, by End-user
11. Global Veterinary Molecular Diagnostics Market Analysis, by Region
11.1. Global Veterinary Molecular Diagnostics Market Scenario, by Region/Country
11.2. Global Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Region
11.3. Global Veterinary Molecular Diagnostics Market Forecast, by Region
11.3.1. North America
11.3.2. Europe
11.3.3. Asia Pacific
11.3.4. Latin America
11.3.5. Middle East & Africa
12. North America Veterinary Molecular Diagnostics Market Analysis
12.1. North America Veterinary Molecular Diagnostics Market Overview
12.2. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country
12.3. North America Veterinary Molecular Diagnostics Market Forecast, by Country
12.3.1. U.S.
12.3.2. Canada
12.4. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
12.5. North America Veterinary Molecular Diagnostics Market Forecast, by Product Type
12.5.1. Instruments & Software
12.5.2. Kits & Reagents
12.5.3. Services
12.6. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
12.7. North America Veterinary Molecular Diagnostics Market Forecast, by Technology
12.7.1. Conventional PCR
12.7.2. Singleplex PCR
12.7.3. Multiplex PCR
12.7.4. Real-time PCR
12.7.5. Others
12.8. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
12.9. North America Veterinary Molecular Diagnostics Market Forecast, by Disease Type
12.9.1. Vector-borne Diseases
12.9.2. Respiratory Pathogens
12.9.3. Diarrhea Pathogens
12.9.4. Others
12.10. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
12.11. North America Veterinary Molecular Diagnostics Market Forecast, by Animal Type
12.11.1. Companion Animals
12.11.1.1. Canine
12.11.1.2. Feline
12.11.1.3. Others
12.11.2. Livestock Animals
12.12. North America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
12.13. North America Veterinary Molecular Diagnostics Market Forecast, by End-user
12.13.1. Hospitals/Clinics
12.13.2. Reference Laboratories
13. Europe Veterinary Molecular Diagnostics Market Analysis
13.1. Europe Veterinary Molecular Diagnostics Market Overview
13.2. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
13.3. Europe Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
13.3.1. Germany
13.3.2. U.K.
13.3.3. France
13.3.4. Italy
13.3.5. Spain
13.3.6. Rest of Europe
13.4. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
13.5. Europe Veterinary Molecular Diagnostics Market Forecast, by Product Type
13.5.1. Instruments & Software
13.5.2. Kits & Reagents
13.5.3. Services
13.6. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
13.7. Europe Veterinary Molecular Diagnostics Market Forecast, by Technology
13.7.1. Conventional PCR
13.7.2. Singleplex PCR
13.7.3. Multiplex PCR
13.7.4. Real-time PCR
13.7.5. Others
13.8. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
13.9. Europe Veterinary Molecular Diagnostics Market Forecast, by Disease Type
13.9.1. Vector-borne Diseases
13.9.2. Respiratory Pathogens
13.9.3. Diarrhea Pathogens
13.9.4. Others
13.10. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
13.11. Europe Veterinary Molecular Diagnostics Market Forecast, by Animal Type
13.11.1. Companion Animals
13.11.1.1. Canine
13.11.1.2. Feline
13.11.1.3. Others
13.11.2. Livestock Animals
13.12. Europe Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
13.13. Europe Veterinary Molecular Diagnostics Market Forecast, by End-user
13.13.1. Hospitals/Clinics
13.13.2. Reference Laboratories
14. Asia Pacific Veterinary Molecular Diagnostics Market Analysis
14.1. Asia Pacific Veterinary Molecular Diagnostics Market Overview
14.2. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
14.3. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
14.3.1. China
14.3.2. Japan
14.3.3. India
14.3.4. Australia & New Zealand
14.3.5. Rest of Asia Pacific
14.4. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
14.5. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Product Type
14.5.1. Instruments & Software
14.5.2. Kits & Reagents
14.5.3. Services
14.6. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
14.7. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Technology
14.7.1. Conventional PCR
14.7.2. Singleplex PCR
14.7.3. Multiplex PCR
14.7.4. Real-time PCR
14.7.5. Others
14.8. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
14.9. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Disease Type
14.9.1. Vector-borne Diseases
14.9.2. Respiratory Pathogens
14.9.3. Diarrhea Pathogens
14.9.4. Others
14.10. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
14.11. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by Animal Type
14.11.1. Companion Animals
14.11.1.1. Canine
14.11.1.2. Feline
14.11.1.3. Others
14.11.2. Livestock Animals
14.12. Asia Pacific Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
14.13. Asia Pacific Veterinary Molecular Diagnostics Market Forecast, by End-user
14.13.1. Hospitals/Clinics
14.13.2. Reference Laboratories
15. Latin America Veterinary Molecular Diagnostics Market Analysis
15.1. Latin America Veterinary Molecular Diagnostics Market Overview
15.2. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
15.3. Latin America Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
15.3.1. Brazil
15.3.2. Mexico
15.3.3. Rest of Latin America
15.4. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
15.5. Latin America Veterinary Molecular Diagnostics Market Forecast, by Product Type
15.5.1. Instruments & Software
15.5.2. Kits & Reagents
15.5.3. Services
15.6. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
15.7. Latin America Veterinary Molecular Diagnostics Market Forecast, by Technology
15.7.1. Conventional PCR
15.7.2. Singleplex PCR
15.7.3. Multiplex PCR
15.7.4. Real-time PCR
15.7.5. Others
15.8. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
15.9. Latin America Veterinary Molecular Diagnostics Market Forecast, by Disease Type
15.9.1. Vector-borne Diseases
15.9.2. Respiratory Pathogens
15.9.3. Diarrhea Pathogens
15.9.4. Others
15.10. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
15.11. Latin America Veterinary Molecular Diagnostics Market Forecast, by Animal Type
15.11.1. Companion Animals
15.11.1.1. Canine
15.11.1.2. Feline
15.11.1.3. Others
15.11.2. Livestock Animals
15.12. Latin America Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
15.13. Latin America Veterinary Molecular Diagnostics Market Forecast, by End-user
15.13.1. Hospitals/Clinics
15.13.2. Reference Laboratories
16. Middle East & Africa Veterinary Molecular Diagnostics Market Analysis
16.1. Middle East & Africa Veterinary Molecular Diagnostics Market Overview
16.2. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Country/Sub-region
16.3. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Country/Sub-region
16.3.1. GCC Countries
16.3.2. South Africa
16.3.3. Rest of Middle East & Africa
16.4. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Product Type
16.5. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Product Type
16.5.1. Instruments & Software
16.5.2. Kits & Reagents
16.5.3. Services
16.6. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Technology
16.7. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Technology
16.7.1. Conventional PCR
16.7.2. Singleplex PCR
16.7.3. Multiplex PCR
16.7.4. Real-time PCR
16.7.5. Others
16.8. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Disease Type
16.9. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Disease Type
16.9.1. Vector-borne Diseases
16.9.2. Respiratory Pathogens
16.9.3. Diarrhea Pathogens
16.9.4. Others
16.10. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by Animal Type
16.11. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by Animal Type
16.11.1. Companion Animals
16.11.1.1. Canine
16.11.1.2. Feline
16.11.1.3. Others
16.11.2. Livestock Animals
16.12. Middle East & Africa Veterinary Molecular Diagnostics Market Value Share and Attractiveness Analysis, by End-user
16.13. Middle East & Africa Veterinary Molecular Diagnostics Market Forecast, by End-user
16.13.1. Hospitals/Clinics
16.13.2. Reference Laboratories
17. Competition Landscape
17.1. Competition Matrix
17.2. Global Veterinary Molecular Diagnostics Market Share Analysis, by Company
17.3. Company Profiles
17.3.1. IDEXX Laboratories, Inc.
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Financial Overview
17.3.1.3. Product Portfolio
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Thermo Fisher Scientific, Inc.
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Financial Overview
17.3.2.3. Product Portfolio
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Zoetis, Inc.
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Financial Overview
17.3.3.3. Product Portfolio
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Neogen Corporation
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. SWOT Analysis
17.3.4.4. Strategic Overview
17.3.5. bioMérieux SA
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Financial Overview
17.3.5.3. Product Portfolio
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. QIAGEN N.V.
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Financial Overview
17.3.6.3. Product Portfolio
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Biomedica Medizinprodukte GmbH & Co KG
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. SWOT Analysis
17.3.7.4. Strategic Overview
17.3.8. Bioneer
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. SWOT Analysis
17.3.8.4. Strategic Overview
17.3.9. VCA, Inc. (subsidiary of Mars, Incorporated)
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. SWOT Analysis
17.3.9.4. Strategic Overview
17.3.10. ID.VET
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. SWOT Analysis
17.3.10.4. Strategic Overview
List of Tables
Table 01: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 02: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 03: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 04: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 05: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 06: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 07: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Region, 2018–2030
Table 08: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Country, 2018–2030
Table 09: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 10: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 11: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 12: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 13: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 14: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 15: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 16: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 17: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 18: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 19: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 20: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 21: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 22: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 23: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 24: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 25: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 26: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 27: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 28: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 29: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 30: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 31: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 32: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 33: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 34: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 35: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
Table 36: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Countries/Sub-region, 2018–2030
Table 37: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Product Type, 2018–2030
Table 38: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Technology, 2018–2030
Table 39: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Disease Type, 2018–2030
Table 40: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Animal Type, 2018–2030
Table 41: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by Companion Animal, 2018–2030
Table 42: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2018–2030
List of Figures
Figure 01: Global Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast, 2018–2030
Figure 02: Global Veterinary Molecular Diagnostics Market Value Share, by Product Type, 2019
Figure 03: Global Veterinary Molecular Diagnostics Market Value Share, by Distribution Channel, 2019
Figure 04: Global Veterinary Molecular Diagnostics Market Value Share, by Disease Type, 2019
Figure 06: Global Veterinary Molecular Diagnostics Market Value Share, by Animal Type, 2019
Figure 07: Global Veterinary Molecular Diagnostics Market Value Share, by End-user, 2019
Figure 08: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 09: Global l Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 10: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Instruments & Software, 2018–2030
Figure 11: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Kits & Reagents, 2018–2030
Figure 12: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Services, 2018–2030
Figure 13: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 14: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030
Figure 15: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Conventional PCR, 2018–2030
Figure 16: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Singleplex PCR, 2018–2030
Figure 17: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Multiplex PCR, 2018–2030
Figure 18: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Real-time PCR, 2018–2030
Figure 19: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Others, 2018–2030
Figure 20: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030
Figure 21: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030
Figure 22: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Vector-borne Diseases, 2018–2030
Figure 23: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Respiratory Pathogens, 2018–2030
Figure 24: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Diarrhea Pathogens, 2018–2030
Figure 25: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Others, 2018–2030
Figure 26: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030
Figure 27: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030
Figure 28: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Companion Animals, 2018–2030
Figure 29: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Livestock Animals, 2018–2030
Figure 30: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 31: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 32: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Hospitals/Clinics, 2018–2030
Figure 33: Global Veterinary Molecular Diagnostics Market Value (US$ Mn), by Reference Laboratories, 2018–2030
Figure 34: Global Veterinary Molecular Diagnostics Market Value Share Analysis, by Region, 2019 and 2030
Figure 35: Global Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Region
Figure 36: North America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 37: North America Veterinary Molecular Diagnostics Market Value Share (%), by Country, 2019 and 2030
Figure 38: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country, 2020–2030
Figure 39: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 40: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 41: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 42: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030
Figure 43: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030
Figure 44: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030
Figure 45: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030
Figure 46: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030
Figure 47: North America Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 48: North America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 49: Europe Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 50: Europe Veterinary Molecular Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 51: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 52: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 53: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 54: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 55: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030
Figure 56: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030
Figure 57: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030
Figure 58: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030
Figure 59: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030
Figure 60: Europe Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 61: Europe Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 62: Asia Pacific Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 63: Asia Pacific Veterinary Molecular Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 64: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 65: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 66: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 67: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 68: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030
Figure 69: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030
Figure 70: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030
Figure 71: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030
Figure 72: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030
Figure 73: Asia Pacific Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 74: Asia Pacific Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 75: Latin America Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 76: Latin America Veterinary Molecular Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 77: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 78: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 79: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 80: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 81: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030
Figure 82: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030
Figure 83: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030
Figure 84: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030
Figure 85: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030
Figure 86: Latin America Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 87: Latin America Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Figure 88: Middle East & Africa Veterinary Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2030
Figure 89: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share (%), by Country/Sub-region, 2019 and 2030
Figure 90: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2020–2030
Figure 91: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Product Type, 2019 and 2030
Figure 92: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Product Type, 2020–2030
Figure 93: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Technology, 2019 and 2030
Figure 94: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Technology, 2020–2030
Figure 95: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Disease Type, 2019 and 2030
Figure 96: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Disease Type, 2020–2030
Figure 97: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by Animal Type, 2019 and 2030
Figure 98: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by Animal Type, 2020–2030
Figure 99: Middle East & Africa Veterinary Molecular Diagnostics Market Value Share Analysis, by End-user, 2019 and 2030
Figure 100: Middle East & Africa Veterinary Molecular Diagnostics Market Attractiveness Analysis, by End-user, 2020–2030
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
*86 figures and 60 tables includes